LATEST ALERTS
Cannabinoids
Japan cannabinoid conference-goers look forward to future with legal reforms
9th January 2023 - News analysis |
There are high hopes for the Japanese cannabinoid sector ahead of the legal reforms expected later this year, according to speakers at the CBD Journey Vol. 4 and CannaCon 2022 event and conference held at the end of 2022
Monaco: CBD and cannabis regulation, January 2023
9th January 2023 - Regulatory reports |
This report provides a detailed summary of the current regulations in place for hemp, cannabis and CBD in Monaco, covering all areas from cultivation and processing to extracts and finished products
Australia: CBD and cannabis regulation, January 2023
4th January 2023 - Regulatory reports |
This report provides a detailed overview of Australia’s federal and state regulation of hemp, CBD and cannabis, covering everything from cultivation to extracts and finished products, as well as the medical and recreational cannabis regimes
Is 2023 the year for the great leap forward on cannabis regulation?
3rd January 2023 - News analysis |
Will 2023 be the year that some fairly major changes start to roll in for cannabis and cannabinoids? It’s possible
An overview of intoxicating hemp-derived cannabinoids in Europe
2nd January 2023 - Regulatory reports |
This report examines the basic regulatory framework for the most popular IHDC product categories and identifies the IHDC product that is most likely to be allowed in Europe
US FDA again issues warning letters on CBD in ingestibles, this time with a twist
30th December 2022 - News analysis |
The FDA has made clear for years that CBD in food is illegal in the US, as it violates the Federal Food, Drug, and Cosmetic (FD&C) Act. What’s different this time?
A watershed year? 2022 sees cannabis on the rise, while CBD goes downhill
30th December 2022 - News analysis |
This past year has seen a curious crossing of paths in the world of cannabis and cannabinoids, with concerns around CBD increasing even as many countries make moves towards the legalisation of cannabis
The question of semi-synthetics – HHC comes under scrutiny by EU authorities
29th December 2022 - News analysis |
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has begun the process of collecting data and evaluating the risk posed by hexahydrocannabinol (HHC) and other semi-synthetic cannabinoids
As legal cannabinoid markets spread, UN considers vexed question of regulation
20th December 2022 - News analysis |
The United Nations may be growing more accepting of a global legal cannabinoid sector, but it does not believe many countries have the capacity to successfully regulate such markets
Hong Kong to ban CBD in the new year, ending a once-burgeoning business
19th December 2022 - News analysis |
The sale and possession of CBD will be banned in Hong Kong from the beginning of February 2023 following an announcement earlier this year. Under the new rules, CBD will be classified in the same way as heroin and cocaine
Minister responds to ACMD research on subject of research barriers…
19th December 2022 - Alerts | Europe, United Kingdom |
Government publishes Q&A on cooperatives and cannabis…
19th December 2022 - Alerts | Argentina, South America |
Anvisa authorises cannabis cultivation for research purposes…
19th December 2022 - Alerts | Brazil, South America |
Italy: CBD and cannabis regulation, December 2022
19th December 2022 - Regulatory reports |
This report provides a detailed overview of the current regulatory framework in place for CBD, hemp and cannabis, covering all policy areas
Executives acquitted of fraud relating to cannabis production…
16th December 2022 - Alerts | Canada, North America |
Germany: CBD and cannabis snapshot
15th December 2022 - Market reports , Regulatory reports |
This snapshot of Germany’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
Spain: CBD and cannabis snapshot
14th December 2022 - Market reports , Regulatory reports |
This snapshot of Spain’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
Medical Marijuana and Cannabidiol Research Expansion Act signed into law…
5th December 2022 - Alerts | North America, United States |
Global cannabinoid vape compliance database
2nd December 2022 - Regulatory databases |
The cannabinoid vape compliance database goes beyond the legality of cannabinoid-containing vaping products and provides regulatory information on how they can reach the market and thrive
Province lifts ban on some cannabis vapes…
2nd December 2022 - Alerts | Canada, North America |
Netherlands: CBD and cannabis snapshot
30th November 2022 - Market reports , Regulatory reports |
This snapshot of the Netherland’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
Global cannabis stakeholders database
30th November 2022 - Regulatory databases |
CannIntelligence’s directory of stakeholders in the global cannabis sector allows you to find the most relevant organisations in key markets, with full web, email, phone and address details.
France: CBD and cannabis snapshot
29th November 2022 - Market reports , Regulatory reports |
This snapshot of France’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
Grey area over medical cannabis regime in Mexico leaves industry pessimistic
28th November 2022 - News analysis |
Members of the Mexican cannabis sector have told CannIntelligence they are pessimistic about whether the framework to regulate the national medical cannabis industry will be implemented before 2024
Tilray bets on cannabis-infused drinks, grows distribution network in the US
25th November 2022 - News analysis |
Tilray Brands continues to show signs of confidence in the future of cannabis-infused drinks by adding more beverage firms to its portfolio and building a distribution network
Lebanon: CBD and cannabis regulation, November 2022
24th November 2022 - Regulatory reports |
This report provides a detailed overview of the current regulatory framework in place in Lebanon for hemp, cannabinoids such as CBD, and cannabis
How will the midterm shift in the balance of power in Washington affect cannabis?
23rd November 2022 - News analysis |
The predicted Red Wave never arrived – but how have the prospects for cannabis-related federal legislation in the US been changed by the midterm elections? US correspondent James DeLise considers the new balance of power in Washington
UK FSA novel food process can succeed with ‘supportive and sensible approach’
21st November 2022 - News analysis |
A cannabis regulation lawyer believes the UK Food Standards Agency (FSA) and the CBD sector have invested so much time, effort and money in the novel food process that it cannot be allowed to fail
Biden to sign bill on medical cannabis and CBD research…
21st November 2022 - Alerts | North America, United States |
US Major League Baseball makes deal with CBD company Charlotte’s Web
18th November 2022 - News analysis |
In an exclusive partnership with Charlotte’s Web, Major League Baseball (MLB) has become the first of the major US sports leagues to sign a deal with a cannabinoid company
US medical cannabis and CBD research bill sent for presidential approval…
17th November 2022 - Alerts | North America, United States |
More validated but no light at the end of the tunnel for Efsa’s novel food applicants
16th November 2022 - News analysis |
Nearly six months after the European Food Safety Authority (Efsa) put novel food assessments for cannabinoids on hold, none of the validated applicants has been able to fill the identified knowledge gaps
Sweden’s turn to the right may have shut down hopes of liberalisation on cannabis
15th November 2022 - News analysis |
Sweden’s general election in September was not good news for cannabis advocates, with the new right-wing bloc minority government likely to take a highly restrictive view, while cannabinoids are not high on its agenda
US FDA to ‘advance efforts’ on cannabis research and law with new appointee
14th November 2022 - News analysis |
The US Food and Drug Administration (FDA) recently appointed Norman Birenbaum to a top post as a senior public health adviser in the FDA’s Center for Regulatory Programs, signalling a seismic shift at the agency
Netherlands: CBD and cannabis regulation, November 2022
11th November 2022 - Regulatory reports |
This report provides a detailed overview of the current regulatory framework in place in the Netherlands for hemp, cannabinoids such as CBD and cannabis
$0 to $7.8m in three months – tobacco firm cashes in on cannabis and hemp
9th November 2022 - News analysis |
US tobacco company 22nd Century Group has enjoyed its first full quarter benefitting from revenue generated by its new hemp/cannabis business arm
First licence is approved to cultivate hemp…
7th November 2022 - Alerts | Central America, Costa Rica |
Mexico cannabis industry doubtful of recreational bill approval before 2024
7th November 2022 - News analysis |
Legal hurdles impeding recreational cannabis legalisation in Mexico are expected to continue through 2024, industry members told CannIntelligence during the CannaMexico conference last month
OPH makes recommendations for Cannabis Act Review…
4th November 2022 - Alerts | Canada, North America |
The UDAF steps up enforcement efforts on synthetic and derivative cannabinoids…
4th November 2022 - Alerts | North America, United States, Utah |
Ambitious German startup puts its Signature on Ccell CBD vaping devices
3rd November 2022 - News analysis |
German hemp supplier Signature Products is taking a step back to its roots, saying it will step up its marketing of Ccell vape devices that can be filled with CBD extracts
Austria’s ‘Kafkaesque’ politics keep medical cannabis tied up in knots
1st November 2022 - News analysis |
Austria’s almost non-existent regime for the use of cannabinoids in medication has been described as “a Kafkaesque nightmare” with over-officious bureaucracy putting pointless hurdles in patients’ way
